Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emily A. Contreras"'
Autor:
Elan J. Portner, Tor Mowatt-Larssen, Alejandro Cano-Lasso Carretero, Emily A. Contreras, Phoebe A. Woodworth-Jefcoats, Benjamin W. Frable, C. Anela Choy
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract Pelagic predators are effective biological samplers of midtrophic taxa and are especially useful in deep-sea habitats where relatively mobile taxa frequently avoid observation with conventional methods. We examined specimens sampled from the
Externí odkaz:
https://doaj.org/article/52ff79afd2de44f482273b141cb3ccd9
Autor:
Jonathan L. Whitney, Jamison M. Gove, Margaret A. McManus, Katharine A. Smith, Joey Lecky, Philipp Neubauer, Jana E. Phipps, Emily A. Contreras, Donald R. Kobayashi, Gregory P. Asner
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-18 (2021)
Abstract Most marine animals have a pelagic larval phase that develops in the coastal or open ocean. The fate of larvae has profound effects on replenishment of marine populations that are critical for human and ecosystem health. Larval ecology is ex
Externí odkaz:
https://doaj.org/article/87034c249b0b477a8b8ac12a345e75ec
Autor:
Karla B. Balagso, Gregory P. Asner, Gareth J. Williams, Jeffrey J. Polovina, Jennifer M. Lynch, Philipp Neubauer, Donald R. Kobayashi, Katharine A. Smith, Mark A. Merrifield, Margaret A. McManus, Jana E. Phipps, Felipe Carvalho, Jonathan L. Whitney, Joey Lecky, Jiwei Li, Emily A. Contreras, Jamison M. Gove, Mark E. Manuel, Jeffrey Maynard
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance Many of the world’s marine fish spend the first days to weeks feeding and developing at the ocean surface. However, very little is known about the ocean processes that govern larval fish survivorship and hence adult fish populations th
Autor:
Emily M. Contreras, Sandeep K. Gupta
Publikováno v:
Gastroenterology clinics of North America. 43(2)
Swallowed fluticasone and oral viscous budesonide are effective first-line therapies for eosinophilic esophagitis in children. Side effects are minimal without evidence of Cushing syndrome, as seen in treatment with systemic corticosteroids. New stud